Acute Cholecystitis Market is expected to grow at a CAGR of 5.93% through 2031
Changing
lifestyles and eating habits are driving the growth in Global Acute
Cholecystitis Market in the forecast period, 2027-2031.
According to TechSci Research report, “Acute
Cholecystitis Market - Global Industry Size,
Share, Trends, Opportunity and Forecast, 2021-2031F”, The Global Acute Cholecystitis Market will grow from USD 2.64 Billion in 2025 to USD 3.73 Billion by 2031 at a 5.93% CAGR, with an impressive CAGR on
the account of rising instances of patients suffering from the gall bladder
stone conditions. The accumulation of compounds such as calcium carbonate, palmitate phosphate, bilirubin, and other bile pigments causes acute cholecystitis.
The geriatric population is highly affected by the condition due to their weak gastrointestinal tract and weaker digestive system. The growing geriatric population is also contributing to the growth of the global acute cholecystitis market over the next five years. Moreover, hthe ealthcare industry
is consistently involved in advanced research and technological developments.
This has provided patients with earlier diagnosis, more efficient treatment, and improved outcomes, which are driving market growth.
Additionally, changes in the population's eating habits are increasing the risk of developing the condition and are expected to drive market growth over the next five years. The young population is heavily inclined toward snacks and fast food, which have adverse health effects and increase the population's risk of developing the condition. According to recent research reports, more than 20% young population in the
United States suffer from gallstones that further leads to cholecystitis.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Acute Cholecystitis Market"
https://www.techsciresearch.com/report/acute-cholecystitis-market/9316.html
The global acute cholecystitis market is segmented
by type, cause, diagnostic procedure, treatment, end user, regional
distribution, and competitive landscape. Based on cause, the market is
differentiated into gall bladder stones, tumor, bile duct blockage, microbial
infection, and others. Gall bladder stones are the primary and most presumptuous
cause of acute cholecystitis.
Due to unhealthy eating habits and weakened digestive systems, the accumulation of calcium derivatives in the gallbladder is pronounced. These factors are supporting the fact that gall bladder stones are
the most possible cause of acute cholecystitis. Moreover, the increasing instances of gastrointestinal cancer and tumours are also increasing and are a major cause behind the increased cases of acute cholecystitis in the upcoming five years.
Based on type, the market is further divided into calculous and acalculous acute cholecystitis.
Depending on the obstruction site the acute cholecystitis is of two kinds. Acute cholecystitis is a medical condition in which stone-like obstructions form in the gallbladder or in the bile duct that connects the gallbladder to the small intestine.
If the obstruction is at the gall bladder duct it
is termed as calculous acute cholecystitis and if the obstruction is at any
other site in the gall bladder or the tube, it is termed as acalculous acute
cholecystitis. Calculous acute cholecystitis is a worse condition of gall
bladder condition. It requires immediate attention thereby is anticipated to
hold the larger market revenue shares and assert its dominance over the market
segment. Acalculous acute cholecystitis is also an emergency situation but is
comparatively less painful and may register significant growth in the market
shares in the next five years.
Holding the major shares of the global acute
cholecystitis market are:
- Boston Scientific Corporation
- Fresenius Kabi AG
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Merck & Co. Inc.
- Becton, Dickinson and Company
- Simulab Corporation
- AbbVie Inc.
- Fortimedix Surgical BV
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=9316
Customers can also request for 10% free customization on this report.
“North America regionally supports the best healthcare industry
in the world. Economies like United States, Canada has the most versatile and
developed healthcare sector and are anticipated to support the claim of North
America being the most promising region for the market growth in the future
five years. United States even has a large population suffering from the
condition and aiding the growth of the market. The Asia-Pacific region is expected to be the fastest-growing market and achieve the highest CAGR over the next five years. The countries in the region like India, China, and Japan, are
consistently evolving and advancing their healthcare sector. With evolved
pharmaceutical sector, and better treatment possibilities along with the
affordable rates of the treatment and diagnosis, the region is bound to be an
advantageous section for the new market players. New market entrants must
invest in research and technological advancements for the future endeavors,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based Global management consulting firm.
“Acute Cholecystitis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Calculous Acute Cholecystitis v/s Acalculous Acute Cholecystitis) By Cause (Gall Bladder Stones, Tumor, Bile Duct Blockage, Microbial Infection, Others) By Diagnostic Procedure (Ultrasonography, Cholescintigraphy, CT Scan, ERCP (Endoscopic Retrograde Cholangiopancreatography), Others) By Treatment (Surgical v/s Non-Surgical) By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) By Region 2021-2031F”, has evaluated the future growth
potential of global acute cholecystitis and provides statistics &
information on market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global acute cholecystitis market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/